U.K. Biotechs brush off Leschly's comments

In London, twenty-one of over forty biotech shares were down on Monday, led by drug discovery play Oxford GlycoSciences (LSE:OGS), which was down 130p (7.4 percent) to 1625p. OGS's move, however, was ...